Last update 01 Nov 2024

Anti-FCRL5 CAR-T (Xuzhou Medical University)

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms-
Target
FCRL5
Mechanism
FCRL5 inhibitors(Fc receptor-like protein 5 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesCardiovascular Diseases+ [2]
Active Indication
Plasma cell myeloma refractoryRelapse multiple myeloma
Inactive Indication-
Originator Organization
Xuzhou Medical UniversityXuzhou Medical University
Active Organization
Xuzhou Medical UniversityXuzhou Medical University
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Anti-FCRL5 CAR-T (Xuzhou Medical University)
NCT06196255 / RecruitingPhase 1/2IIT
Efficacy and Safety Study of Anti-FcRL5 CAR-T Cells in Subjects With Relapsed and Refractory Multiple Myeloma
100 Clinical Results associated with Anti-FCRL5 CAR-T (Xuzhou Medical University)
Login to view more data
100 Translational Medicine associated with Anti-FCRL5 CAR-T (Xuzhou Medical University)
Login to view more data
100 Patents (Medical) associated with Anti-FCRL5 CAR-T (Xuzhou Medical University)
Login to view more data
100 Deals associated with Anti-FCRL5 CAR-T (Xuzhou Medical University)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Plasma cell myeloma refractoryPhase 2
CN
Xuzhou Medical UniversityXuzhou Medical University
25 Dec 2023
Relapse multiple myelomaPhase 2
CN
Xuzhou Medical UniversityXuzhou Medical University
25 Dec 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free